Biomarkers for the diagnosis of acute kidney injury

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 6, 2007, Pages 557-564

  Waikar, Sushrut S ^a   Bonventre, Joseph V ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute kidney injury; Acute renal failure; Biomarker; Diagnosis

Indexed keywords

ADENOSINE DEAMINASE; ALKALINE PHOSPHATASE; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; BETA GALACTOSIDASE; BIOLOGICAL MARKER; CREATININASE; CYTOSOL AMINOPEPTIDASE; ENDOTHELIN 1; FATTY ACID BINDING PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GELATINASE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE P1; INTERLEUKIN 18; LACTATE DEHYDROGENASE; LIPOCALIN; MEMBRANE METALLOENDOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN; TROPONIN; UNCLASSIFIED DRUG;

CLINICAL PRACTICE; CLINICAL STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME DEFECT; GLOMERULUS FILTRATION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TUBULE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; UREA NITROGEN BLOOD LEVEL;

BIOLOGICAL MARKERS; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS;

EID: 37349027984     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3282f08745     Document Type: Review

References (75)

1. Bagshaw SM, Langenberg C, Bellomo R. Urinary biochemistry and microscopy in septic acute renal failure: a systematic review. Am J Kidney Dis 2006; 48:695-705.
2. Chew SL, Lins RL, Daelemans R, et al. Urinary enzymes in acute renal failure. Nephrol Dial Transplant 1993; 8:507-511.
3. Eijkenboom JJ, van Eijk LT, Pickkers P, et al. Small increases in the urinary excretion of glutathione S-transferase A1 and P1 after cardiac surgery are not associated with clinically relevant renal injury. Intensive Care Med 2005; 31:664-667.
4. Hamada Y, Kanda T, Anzai T, et al. N-acetyl-beta-D-glucosaminidase is not a predictor, but an indicator of kidney injury in patients with cardiac surgery. J Med 1999; 30:329-336.
5. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238.
6. Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105:485-491.
7. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Neutrophilgelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 2006; 26:287-292.
8. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6:1639-1645.
9. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70:199-203.
10. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16:3046-3052.
11. du Cheyron D, Daubin C, Poggioli J, et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 2003; 42:497-506.
12. Han WK, Bailly V, Abichandani R, et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62:237-244.
13. Liangos O, Perianayagam MC, Vaidya VS, et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18:904-912. Prediction of adverse clinical outcomes is another potential role for biomarkers in addition to early identification of AKI. This carefully conducted study showed some promise in the use of NAG and KIM-1 for determining prognosis in critically ill patients with established AKI.
14. Nakamura T, Sugaya T, Node K, et al. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006; 47:439-444. This describes a potentially promising biomarker, but confirmatory studies are needed.
15. Fujisaki K, Kubo M, Masuda K, et al. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function. Clin Exp Nephrol 2003; 7:279-283.
16. Takeda M, Komeyama T, Tsutsui T, et al. Changes in urinary excretion of endothelin-1-like immunoreactivity in patients with testicular cancer receiving high-dose cisplatin therapy. Am J Kidney Dis 1994; 24:12-16.
17. Boldt J, Brenner T, Lang J, et al. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg 2003; 97:1582-1589.
18. Jorres A, Kordonouri O, Schiessler A, et al. Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 1994; 18:565-569.
19. Fauli A, Gomar C, Campistol JM, et al. Pattern of renal dysfunction associated with myocardial revascularization surgery and cardiopulmonary bypass. Eur J Anaesthesiol 2003; 20:443-450.
20. Westhuyzen J, McGiffin DC, McCarthy J, Fleming SJ. Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 1994; 228:123-132.
21. Boldt J, Brenner T, Lehmann A, et al. Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 2003; 75:906-912.
22. Ikeda H, Nagashima K, Okumura H, et al. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II). Eur J Surg Oncol 1988; 14:17-20.
23. Verplanke AJ, Herber RF, de Wit R, Veenhof CH. Comparison of renal function parameters in the assessment of cis-platin induced nephrotoxicity. Nephron 1994; 66:267-272.
24. Goren MP, Wright RK, Horowitz ME. Cumulative renal tubular damage associated with cisplatin nephrotoxicity. Cancer Chemother Pharmacol 1986; 18:69-73.
25. Diener U, Knoll E, Langer B, et al. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum. Clin Chim Acta 1981; 112:149-157.
26. Westhuyzen J, Endre ZH, Reece G, et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 2003; 18:543-551.
27. Herget-Rosenthal S, Poppen D, Husing J, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50:552-558.
28. Etherington C, Bosomworth M, Clifton I, Peckham DG, Conway SP. Measurement of urinary N-acetyl-b-d-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. J Cyst Fibros 2006; 6:67-73.
29. Glass S, Plant ND, Spencer DA. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis. J Cyst Fibros 2005; 4:221-225.
30. Nix DE, Thomas JK, Symonds WT, et al. Assessment of the enzymuria resulting from gentamicin alone and combinations of gentamicin with various beta-lactam antibiotics. Ann Pharmacother 1997; 31:696-703.
31. Kang HK, Kim DK, Lee BH, et al. Urinary N-acetyl-beta-D- glucosaminidase and malondialdehyde as a markers of renal damage in burned patients. J Korean Med Sci 2001; 16:598-602.
32. Win A, Aye K, Tin W, et al. Urinary NAG as an early indicator of renal damage in Russell's viper bite envenomation. Trans R Soc Trop Med Hyg 1996; 90:169-172.
33. Fink JC, Cooper MA, Burkhart KM, et al. Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced 'hepatorenal syndrome'. J Am Soc Nephrol 1995; 6:1655-1660.
34. Jung K, Kirschner P, Wille A, Brien G. Excretion of urinary enzymes after extracorporeal shock wave lithotripsy: a critical reevaluation. J Urol 1993; 149:1409-1413.
35. Assimos DG, Boyce WH, Furr EG, et al. Selective elevation of urinary enzyme levels after extracorporeal shock wave lithotripsy. J Urol 1989; 142:687-690.
36. Sakamoto W, Kishimoto T, Nakatani T, et al. Examination of aggravating factors of urinary excretion of N-acetyl-beta-D-glucosaminidase after extracorporeal shock wave lithotripsy. Nephron 1991; 58:205-209.
37. Roberts DS, Haycock GB, Dalton RN, et al. Prediction of acute renal failure after birth asphyxia. Arch Dis Child 1990; 65:1021-1028.
38. Carraro M, Malalan F, Antonione R, et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol 1998; 8:144-147.
39. Carraro M, Mancini W, Artero M, et al. Dose effect of nitrendipine on urinary enzymes and microproteins following nonionic radiocontrast administration. Nephrol Dial Transplant 1996; 11:444-448.
40. Donadio C, Tramonti G, Lucchesi A, et al. Tubular toxicity is the main renal effect of contrast media. Ren Fail 1996; 18:647-656.
41. Nicot GS, Merle LJ, Charmes JP, et al. Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. Jama 1984; 252:2432-2434.
42. Cavaliere G, Arrigo G, D'Amico G, et al. Tubular nephrotoxicity after intravenous urography with ionic high-osmolal and nonionic low-osmolal contrast media in patients with chronic renal insufficiency. Nephron 1987; 46:128-133.
43. Pai MP, Norenberg JP, Telepak RA, et al. Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate. Antimicrob Agents Chemother 2005; 49:3784-3788.
44. Tolkoff-Rubin NE, Thompson RE, Piper DJ, et al. Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding protein. Nephrol Dial Transplant 1987; 2:143-148.
45. Goren MP, Wright RK, Horowitz ME. Increased levels of urinary adenosine deaminase binding protein in children treated with cisplatin or methotrexate. Clin Chim Acta 1986; 160:157-161.
46. Goren MP, Wright RK, Horowitz ME, Pratt CB. Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding protein. Am J Clin Pathol 1986; 86:780-783.
47. Sarica K, Suzer O, Yaman O, et al. Leucine aminopeptidase enzymuria: quantification of renal tubular damage following extracorporeal shock wave lithotripsy. Int Urol Nephrol 1996; 28:621-626.
48. Schiavon M, Di Landro D, Baldo M, et al. A study of renal damage in seriously burned patients. Burns Incl Therm Inj 1988; 14:107-112.
49. da Silva Magro MC, de Fatima Fernandes Vattimo M. Does urinalysis predict acute renal failure after heart surgery? Ren Fail 2004; 26:385-392.
50. Cressey G, Roberts DR, Snowden CP. Renal tubular injury after infrarenal aortic aneurysm repair. J Cardiothorac Vasc Anesth 2002; 16:290-293.
51. Arici M, Usalan C, Altun B, et al. Radiocontrast-induced nephrotoxicity and urinary alpha-glutathione S-transferase levels: effect of amlodipine administration. Int Urol Nephrol 2003; 35:255-261.
52. Gupta KL, Kalra OP, Malik N, Ganguly NK. Quantitative enzymuria following aorto-renal angiography. J Assoc Physicians India 1999; 47:189-191.
53. Hartmann HG, Braedel HE, Jutzler GA. Detection of renal tubular lesions after abdominal aortography and selective renal arteriography by quantitative measurements of brush-border enzymes in the urine. Nephron 1985; 39:95-101.
54. Blaikley J, Sutton P, Walter M, et al. Tubular proteinuria and enzymuria following open heart surgery. Intensive Care Med 2003; 29:1364-1367.
55. D'Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens 2003; 12:639-643.
56. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14:2534-2543.
57. Melnikov VY, Ecder T, Fantuzzi G, et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 2001; 107:1145-1152.
58. Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43:405-414.
59. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998; 273:4135-4142.
60. Bailly V, Zhang Z, Meier W, et al. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002; 277:39739-39748.
61. Vaidya VS, Ramirez V, Ichimura T, et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006; 290:F517-F529.
62. Dieterle F, Staedtler F, Grenet O, et al. Qualification of biomarkers for regulatory decision making: a kidney safety biomarker project [abstract]. The Toxicologist (Society of Toxicology) 2007; 96:383. Preliminary report from an extensive collaborative effort to identify novel biomarkers of nephrotoxicity for regulatory decision making.
63. van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007; 212:209-217.
64. Vella JP, Harris S, Garrison K, Hoch D, Whiting J, Himmelfarb J. Transcripts for Kidney Injury Molecule-1 (KIM-1) are a specific biomarker predicting delayed graft function in kidney transplantation [abstract]. Am J Transplant 2006; 6(Suppl 2):201.
65. Molls RR, Savransky V, Liu M, et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol 2006; 290:F1187-F1193. This describes a potentially promising biomarker but confirmatory studies are needed.
66. Zhou H, Pisitkun T, Aponte A, et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 2006; 70:1847-1857. This describes a potentially promising biomarker but confirmatory studies are needed.
67. Hoste EA, Kellum JA. Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Crit Care 2006; 12:531-537.
68. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66:1115-1122.
69. Herget-Rosenthal S, Pietruck F, Volbracht L, et al. Serum cystatin C: a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol 2005; 64:41-46.
70. Villa P, Jimenez M, Soriano MC, et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005; 9:R139-R143.
71. Delanaye P, Lambermont B, Chapelle JP, et al. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med 2004; 30:980-983.
72. Cimerman N, Brguljan PM, Krasovec M, et al. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000; 300:83-95.
73. Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 2005; 28:346-349.
74. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65:1416-1421.
75. Mazul-Sunko B, Zarkovic N, Vrkic N, et al. Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients. Nephron Clin Pract 2004; 97:c103-c107.